Literature DB >> 10751402

The activation state of alphavbeta 3 regulates platelet and lymphocyte adhesion to intact and thrombin-cleaved osteopontin.

O Helluin1, C Chan, G Vilaire, S Mousa, W F DeGrado, J S Bennett.   

Abstract

Cleavage of osteopontin by thrombin has been reported to enhance cell adhesion. We asked whether thrombin could regulate the alpha(v)beta(3)-mediated adhesion of platelets and B lymphocytes to this substrate. Although there was no difference in the extent or the avidity of thrombin- and ADP-stimulated platelet adhesion to intact or thrombin-cleaved human osteopontin, both the extent and avidity of phorbol ester-stimulated B cell adhesion to thrombin-cleaved osteopontin was significantly increased. Thus, these data suggest that the ability of alpha(v)beta(3) to recognize osteopontin can be differentially regulated in a cell-specific manner. To localize the alpha(v)beta(3) binding site on osteopontin, we measured cell adhesion to the two thrombin cleavage products of osteopontin and to a series of nested RGD-containing osteopontin peptides cross-linked to albumin. Whereas ADP-stimulated platelets adhered to the amino-terminal but not the carboxyl-terminal osteopontin fragment and to the osteopontin peptide RGDSVVYGLR, phorbol ester-stimulated B cells did not adhere to this peptide, although they did so in the presence of 1 mm Mn(2+). Thus, our data confirm that thrombin cleavage enhances the accessibility of the binding motif for alpha(v)beta(3) on osteopontin, but this enhancement is also a function of the activation state of alpha(v)beta(3). Moreover, they indicate that the sequence RGDSVVYGLR contains sufficient information to specify activation-dependent alpha(v)beta(3)-mediated platelet and lymphocyte adhesion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751402     DOI: 10.1074/jbc.M001529200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

Authors:  D T Denhardt; M Noda; A W O'Regan; D Pavlin; J S Berman
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  Molecular photoacoustic imaging of angiogenesis with integrin-targeted gold nanobeacons.

Authors:  Dipanjan Pan; Manojit Pramanik; Angana Senpan; John S Allen; Huiying Zhang; Samuel A Wickline; Lihong V Wang; Gregory M Lanza
Journal:  FASEB J       Date:  2010-11-19       Impact factor: 5.191

3.  Unique transmembrane domain interactions differentially modulate integrin αvβ3 and αIIbβ3 function.

Authors:  Rustem I Litvinov; Marco Mravic; Hua Zhu; John W Weisel; William F DeGrado; Joel S Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-03       Impact factor: 11.205

Review 4.  Nanomedicine strategies for molecular targets with MRI and optical imaging.

Authors:  Dipanjan Pan; Shelton D Caruthers; Junjie Chen; Patrick M Winter; Angana SenPan; Anne H Schmieder; Samuel A Wickline; Gregory M Lanza
Journal:  Future Med Chem       Date:  2010-03       Impact factor: 3.808

5.  Elevated levels of full-length and thrombin-cleaved osteopontin during acute dengue virus infection are associated with coagulation abnormalities.

Authors:  Haorile Chagan-Yasutan; Talitha Lea Lacuesta; Lishomwa C Ndhlovu; Shigeru Oguma; Prisca Susan A Leano; Elizabeth Freda O Telan; Toru Kubo; Kouichi Morita; Toshimitsu Uede; Efren M Dimaano; Toshio Hattori
Journal:  Thromb Res       Date:  2014-05-14       Impact factor: 3.944

6.  Dentin matrix protein-1 isoforms promote differential cell attachment and migration.

Authors:  Zofia von Marschall; Larry W Fisher
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

Review 7.  Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies.

Authors:  Lunxiu Qin
Journal:  Front Med       Date:  2014-01-25       Impact factor: 4.592

8.  Effect of eptifibatide for acute coronary syndromes: rapid versus late administration--therapeutic yield on platelets (The EARLY Platelet Substudy).

Authors:  Paul A Gurbel; Brian Galbut; Kevin P Bliden; Raymond D Bahr; Matthew T Roe; Victor L Serebruany; W Brian Gibler; Robert H Christenson; E Magnus Ohman
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

9.  Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.

Authors:  Patrick M Winter; Shelton D Caruthers; Huiying Zhang; Todd A Williams; Samuel A Wickline; Gregory M Lanza
Journal:  JACC Cardiovasc Imaging       Date:  2008-09

10.  Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles.

Authors:  Anne H Schmieder; Patrick M Winter; Todd A Williams; John S Allen; Grace Hu; Huiying Zhang; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Journal:  Radiology       Date:  2013-06-14       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.